Header Logo

Connection

Nancy Reau to Drug Resistance, Viral

Back to Details
This is a "connection" page, showing publications Nancy Reau has written about Drug Resistance, Viral.
Nancy Reau
Connection Strength
0.347
Drug Resistance, Viral
  1. Updates on hepatitis C virus therapy in the direct-acting antiviral era. Curr Opin Gastroenterol. 2017 May; 33(3):115-119.
    View in: PubMed
    Score: 0.145
  2. HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape. Liver Int. 2016 Apr; 36(4):488-502.
    View in: PubMed
    Score: 0.131
  3. Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies. J Hepatol. 2018 05; 68(5):895-903.
    View in: PubMed
    Score: 0.038
  4. Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection. N Engl J Med. 2015 Dec 31; 373(27):2608-17.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.